Market Sentiment: Overall investor optimism or pessimism towards biotechnology and healthcare sectors impacts MBLU's price.

Clinical Trial Results: Positive or negative data from MBLU's clinical trials for its drug candidates heavily influences investor confidence.

Regulatory Approvals: FDA or other regulatory body approvals of MBLU's products or therapies are significant price catalysts.

Competition: Actions by competitors in the same therapeutic areas can affect MBLU's market potential and valuation.

Financial Performance: MBLU's revenue, expenses, and cash flow influence investor perception of its long-term viability.

Partnerships and Collaborations: Deals with larger pharmaceutical companies or research institutions can boost MBLU's credibility.

Economic Conditions: Broader economic factors like interest rates and inflation can indirectly affect investor risk appetite.

Management Changes: Changes in MBLU's leadership team can lead to uncertainty or optimism depending on the appointments.

Analyst Ratings: Recommendations from financial analysts can influence investor buying or selling decisions.

News and Media Coverage: Positive or negative news stories about MBLU can quickly impact its stock price.

Technological Advancements: Breakthroughs in related technologies may benefit or hinder MBLU's research and development efforts.

Patent Protection: The strength and duration of MBLU's patents affect its ability to maintain market exclusivity.

Financing Activities: Raising capital through stock offerings can dilute existing shareholders and impact the price.

Mergers and Acquisitions: Rumors or actual M&A activity involving MBLU can cause significant price fluctuations.